mcgurn, a shares jumped 12 percent in premarket trading. this is the 2nd vaccine in the united states to have a stunningly high success rate. last week, pfizer announced that early data shows its mark scene is more than 90 percent effective. meanwhile, the european medicines agency is human medicines committee said it's starting a rolling review of maternal covert $1000.00 vaccine. the regular is already reviewing vaccines from astra zeneca and pfizer, all in an effort to speed up the approval process. now to a coronavirus update over the weekend, the us are past 11000000, new code 1000 cases. this comes only one week after hitting 10000000. that's an average of about 150000 last week. positive test rates and hospitalizations are up across the country, forcing states to place even more restrictions on social gatherings and even travel . the u.s. leads global cases and deaths with more than 246000 teletubbies. meanwhile, countries in europe announced more lockdowns. strict measures are being placed as covert cases continue to search, and sou

jillian: joining me to react is fox news contributor bill mcgurn. good to see you.eact to this morning. you hurt our affiliates reporter say of georgia goes blue this is going to be historic. what is your reaction? >> they are right. georgia doesn't vote for democrats, hasn't since 92 but georgia may be the spoiler for donald trump. if he loses georgia it is hard to hang in in the other states. it would be very difficult. he is contesting the other states, the same way the odds have been against the president after it election night, you have to hold more states than biden, the same way of challenging the state, they are planning on challenges but the question is whether the courts will take them and what the evidence is. jillian: your general reactions what has transpired over the course of the last 3 days. a lot of people are not surprised this will take some time, people expected that but there are surprises in certain states where the president has outperformed expectations. >> it was an incredible elections this way. i believed the president would be a lot clos

in the fight against a covert. 90 we've heard of course from the vaccine from biotech and pfizer mcgurn, are russia's sputnik obviously, also supposedly very effective on so many vaccines in the pipeline. you know, is there a rivalry there? is there a competition, there? is this good bad? is there room for all of them? well, this is a very important question and to be honest, this is a business for pharmaceutical being very clear. and this is certainly a market,, for example, if you remember to birds of flies or a c.e.o., it clearly stated that they are not going to subsidize any vaccine just because that's not in favor of the company, but on controls to ostracize any clearly stated that this is a nonprofit vaccine and therefore the cost is, you know, it's going to go so there is certainly a rivalry, there is a race. but as it asserted, my concern is more to build a safety ethic, ac and the transparency of this. so if i understand correctly, i mean there's room for all of them that could you see in the near future, each vaccine being kind of tailored to specific areas in the world. our

bill mcgurn joins us, fox news contributor. obviously not just pennsylvania.en at 264-214. it may be a state doesn't matter in the electoral college if one of the others is called, what do you make of the state of things here? what do you expect over the next few weeks? >> i expect things to get messier. we made a lot of exemptions. we have different rules for this election, doing a lot of new things and we allowed a lot more latitude. for example i believe votes in pennsylvania can count even if they're received by friday, so forth. some without postmarks. i think the more latitude, the more departure from the norm that you allow the more you're just inevitably inviting lawyers to come in to make these judgment calls. so i think this is very bad for the nation, not just in pennsylvania. it adds to the feeling on either side, i don't know who is going to win but i think whenever the winner is pronounced, it is worse for america if the losers feel not only that they lost but that an election was stolen for them. and again the more, kind of departures from the n

bill mcgurn, your thoughts? >> pretty much the same. look, there's a lot of assumptions here. first, we don't know that he's actually lost the election. yes, the margins are going down in certain areas. i think we kind of expected this one some of the other votes would come in, so that would have to -- it would have to lose first. i think not only would he have to show evidence of widespread fraud, it would have to be the margin not only in his state, in the state that he is alleging, but in enough states where it would make a difference to the election. it would have to be -- so there's a lot of hurdles. i would say that the way the president spoke did seem to signal he was not confident that he would maintain his margins and that he would end up in court. i would also add i'm very confident the supreme court would do the right thing. there are some people saying well, trump appointed three of the justices. i don't think they're going to declare donald trump a winner if he didn't win. i want to see the totals and then i want to see the evidence and i'm hoping that when we hav

with no serious safety concerns, the filing sets up mcgurn as a product to be the 2nd vaccine likely to receive special authorization after one developed by pfizer and bio on 10 are joining me now is young. it's not says he is with the european public health alliance. he is, a board member of the european medicines agency, the e.m.e.a., which is dealing with would earn his request for authorization here in europe. mr. not says it's good to have you on the program. we want to be clear, you're not speaking on behalf of him a but you do know the procedures there. when do you think madonna will be granted approval? thank you very much for having me. well, that remains to be seen. we've seen in recent weeks, a lot of these press releases from several pharmaceutical companies. we've seen candidates, but pharmaceutical companies press release is not necessarily science. it can be marketing but is not science. so where it is very critical point right now, where the regulators, for instance, the european medicines agency in europe, needs to look at all the data and come to its own conclusions

it was finds are in by on tech one week ago it was mcgurn. today, it was astra zeneca that announced promising data about a vaccine that prevents coated nineteen's. just say that hopes are high, would be an understatement. according to trial results, all 3 vaccines are exceeding expectations. their effectiveness is 90 percent or better. and astra zeneca is the 1st promising vaccine that due to its low cost, could be delivered globally. a pandemic prevention for every man and woman, regardless of geography or income. these tiles held a promising formula for ending the covert. 19 pandemic globally, a cheap, effective, easy to distribute that scene. we have to get a lot of people, and i did. we're not thinking about the nation's work in terms of one person. it's time we have to think about vaccinating means to these populations, reducing transmission within those populations, so that we really get on top of this pandemic and not what it now looks like. kentucky ability to contribute chairman, have written, take way. the vaccine was developed at

pharmaceutical mcgurn says early tests show its vaccine is 94.5 percent effective in preventing the virus fellow drug maker. pfizer reported similar results a week ago. and fisher reports now from the white house the number of cases, a sort of states or bring don't reinstating limits on gatherings. closing schools, 1000000 new cases were reported in just 6 days. the virus is killing more than 1000 people in america each day. against that backdrop, another drug company has announced it has made a breakthrough in the hunt for the vaccine. but dana says its drug in early tests shows it's 94 percent effective. we have a lot of work ahead of us knowing the vaccine is going to be a fact. it is great news, but we still need to complete the regulatory process. the company hopes to have the 1st 20000000 doses ready to go before the end of the year, front line workers and those most at risk will be treated 1st before there's a bigger rule out. that's led america's top corporate expert to warn people. they can't relax just yet, the virus is not going to stop and call a timeout. while things change t

difference to the pfizer vaccine, which must be kept at arctic like temperatures at all times the mcgurn, a vaccine can be transported and stored in every day refrigerators. and we're going to says if testing continues to go well, the vaccine should be available by spring of next year. well, the good news comes as u.s. president elect joe biden. scientific advisors are planning to meet with drug makers to map out a nationwide vaccination plan. biden's team is moving forward, the troubled ministration has still offered no assistance. and that just as the u.s. is seeing its biggest spike in corona, virus infections and deaths. since the start of the pandemic, the number of new cases, as you see right here, has more than doubled just in the past month. and while cases are spiking nationwide. the latest hotspots, well, they are in the upper midwest. the states of north and south dakota, wyoming, iowa, and wisconsin, which are reporting record numbers of coded 19 hospitalizations. now in terms of new cases, these are the states that have the highest daily numbers right now. california, texas,

it was fines are in by on tech one week ago it was mcgurn a. today it was astra zeneca that announced promising data about a vaccine that prevents coated 19. just say that hopes are high, would be an understatement. according to trial results, all 3 vaccines are exceeding expectations. their effectiveness is 90 percent or better. and astra zeneca is the 1st promising vaccine that due to its low cost, could be delivered globally. a pandemic prevention for every man and woman, regardless of geography or income. these tiles hold a promising formula for ending the covert. 19 pandemic globally, a cheap, effective, easy to distribute that scene. we have to get a lot of people and i did. we're not thinking about it, but it's nations working in terms of one person, it's time we have to think about vaccinating communities, populations reducing transmission within those populations so that we really get on top of this pandemic. and that's what it now looks like. guns have the ability to contribute, share, and have written a big way. the vaccine was devel

bill mcgurn, your thoughts on this? >> yeah, i had the same thing. i'm not a poll watcher. don't know if there is fraud, i hear anecdotal evidence, so forth. i haven't seen it but i do think things with concern. you know, it seems to me that the key value should be transparency, so when the city of philadelphia decides a court order to keep republican poll watchers out, if that's indeed what they did, that should be very concerning to us. i think the larger picture of this is you look at all the changes we've made an election law -- the other part of pennsylvania that i find outrageous is the supreme court let stand a state court ruling that i think is unconstitution unconstitutional. the law was one thing by the elected representative's, that's where the constitution puts it in the basically extended a deadline on their own. but these individual things add up and i think what it's going to do is no matter who wins or loses, the loser will probably not only think "i've lost the election, but it was stolen from me," and that's a terrible thing for our country and it sort of

in the fight against a covert. 90 we've heard of course from the vaccine from biotech and pfizer mcgurn, are russia's sputnik obviously, also supposedly very effective on so many vaccines in the pipeline. you know, is there a rivalry there? is there a competition, there? is this good bad? is there room for all of them? well, this is really important question and to be honest, if this is a business for pharmaceutical being very clear, and this is certainly a market,, for example, if you remember deferred wiser c.e.o., it clearly stated that they are not going to subsidize any vaccine, just because that's not in favor of the company, but on contrast, australia clearly stated that this is a non profit vaccine and therefore that the cost is, you know, it's going to go. so that is certainly a rivalry that is a race. but as it asserted, my concern is more about the safety ethic, ac, and the transparency of the data. so we will be bringing all of that information to make clear that whatever to vaccine that is ordered into the market is safe and effective and the possible proper checks. so if i

bill mcgurn of "the wall street journal," thank you very much, my friend. other states at play here. jackie deangelis is back with us, she has not slept -- [laughter] so this is going to be funny, just her finding the screen and getting to the stage. the pressure's really on right now because she's had zero sleep, so this should be interesting. >> reporter: thank you. you set a good example, neil. i'm going to hi, my name is sam davis and i'm going to tell you about exciting plans available to anyone with medicare. many plans provide broad coverage and still may save you money on monthly premiums and prescription drugs. with original medicare you're covered for hospital stays and doctor office visits, but you have to meet a deductible for each and then, you're still responsible for 20 percent of the cost. next, let's look at a medicare supplement plan. as you can see they cover the same things as original medicare, and they also cover your medicare deductibles and co-insurance, but they often have higher monthly premiums and no prescription drug coverage. n

it was fines are in by on tech one week ago it was mcgurn. today, it was astra zeneca that announced promising data about a vaccine that prevents coated 19. just say that hopes are high, would be an understatement. according to trial results, all 3 vaccines are exceeding expectations. their effectiveness is 90 percent or better. and astra zeneca is the 1st promising bank scene that due to its low cost, could be delivered globally. a pandemic prevention for every man and woman, regardless of geography or income. these tiles hold a promising formula for ending the covert. 19 pandemic globally. a cheap, effective, easy to distribute that scene. we have to get a lot of people, and i did. we're not thinking about the nation's work in terms of one person. it's time we have to think about vaccinating communities, populations, reducing transmission within those populations, so that we really get on top of this pandemic. and that's what it now looks like. ray guns, have the ability to can chip the chairman, have written big way. the vaccine was develo

jillian: giano caldwell, pastor robert jeffress and bill mcgurn of the wall street journal all aheadxt hour. ♪ wow! a new buick? for me? to james, from james. that's just what i wanted. is this a new buick? i secret santa-ed myself. i shouldn't have. but i have been very good this year. wow! wow! wow! this year, turn black friday into buick friday all month long. now during buick friday, pay no interest for 84 months on most 20-20 buick suv models. confusing like, "why am i sitting here in a hospital gown waiting to get my eyes checked?" ready? absolutely not. see, having the wrong coverage can mean you get the wrong care, or you're paying more than you have to. that's why i love healthmarkets, your insurance marketplace. they make sure you have the right coverage, health insurance, medicare, and yes, dental too. wow, think that's painful? wait 'til he gets the bill. a cavity can cost as much as $350 and a root canal, whoa. but with healthmarkets, for less than a dollar a day, you can save a bundle every time you go to the dentist. exams, cleanings, and x-rays, those are covered at 1

. >> trace: let's bring in bill mcgurn from the "wall street journal." fox news contributor.ere watching this. i want to get your take on the breaking news in pennsylvania. really you have a gop-controlled legislature in pennsylvania. we heard from the democratic governor tom wolf. they're at odds over the law that you can accept absentee ballots coming in after election day and that's the thing the supreme court decided not to get involved in for the time being. the question remains this is litigation that could mess up a lot of plans over the next five, six, seven days. >> yeah, i agree with that. i would say pennsylvania invited this kind of outcome and for things to be messed up with litigation by the way they changed the rules. my understanding when the supreme court-up held the court's decision on pennsylvania and the rules, my understanding was that that was just about a stay. in other words, they rejected the republican request for a stay. so that can be revisited. in that short period of time we now have amy coney barrett on the court. it could change a lot. this is

republican strategist lisa boot and bill mcgurn thomas for the wall street journal.onathan, there is way thought about how long this goes on and what the fight looks like. >> it is strange, because you'v got the presidents public comments which are still insisting the election is stolen , that he will emerge victorious, and then you've got what he saying privately which is as we reported, how he's bee talking about potentially setting up some kind of digital media outlet to compete against fox news and then he's got his administration which is acting with urgency to lock in certain policies and personnel before the inauguration. that he will be on the public posture that is the opposite. >> lisa, the public classroom clearly is sending the signal that this is going to be fought every legal ballots counted in every state until every judge throws it out of every state. >> we're going to have a recoun in georgia this probably going to be a recount in wisconsin, a lawsuit pending and a handful. today as john roberts noted, earlier on in the show, yet the secretary of sta

to run outs as republicans push to maintain control to live report and "fox news" contributor bill mcgurn on what it all means for the balance of power. living with bipolar depression. emptiness. a hopeless struggle. the lows of bipolar depression can disrupt your life and be hard to manage. latuda could make a real difference in your symptoms. latuda was proven to significantly reduce bipolar depression symptoms, and in clinical studies, had no substantial impact on weight. now i'm feeling connected. empowered. latuda is not for everyone. call your doctor about unusual mood changes, behaviors or suicidal thoughts. antidepressants can increase these in children, teens, and young adults. elderly dementia patients on latuda have an increased risk of death or stroke. call your doctor about fever, stiff muscles, and confusion, as these may be life-threatening, or uncontrollable muscle movements as these may be permanent. these are not all the serious side effects. this is where i want to be. talk to your doctor and ask if latuda could make the difference you've been looking for in your bipola

it was fines are in by on tech one week ago it was mcgurn. today, it was astra zeneca that announced promising data about a vaccine that prevents coated 19. just say that hopes are high, would be an understatement. according to trial results, all 3 vaccines are exceeding expectations. their effectiveness is 90 percent or better. and astra zeneca is the 1st promising vaccine that due to its low cost, could be delivered globally. a pandemic prevention for every man and woman, regardless of geography or income. these tiles hold a promising formula for ending the covert. 19 pandemic globally. a cheap, effective, easy to distribute that scene. we have to get a lot of people. that's why did we not thinking about the nation's working times of one person? it's time we have to think about vaccinating communities, populations, reducing transmission within those populations, so that we really get on top of this pandemic and not what it now looks like. guns have been a teach. you can chip the chair in a really big way. the vaccine was developed at the u.

i love bill mcgurn's column every week in "the wall street journal." i especially love it today, because it begins talking about the hypocrisy, and the hypocritical behavior of leaders. whether it is a cuomo or a gavin newsom, most especially. the reason the hypocritical behavior emerges is because these rules, these edicts, these orders they've handed down, they can't even abide by them, and they don't make any sense. bill writes this. "we impose one-size-fits-all mandates that are rigid and unworkable. there's no nuance to them. there is a professor of public health at the university of north carolina who wrote a book about this, saying that many of these mandates and guidelines fixate on behaviors and settings where the actual risk is very low. fleeting public and counters, surface-based transmission, beach visits. so we need to stop -- to paraphrase bill, we need to stop pretending you can eliminate all risk, which you can't. lockdowns merely delay the virus, nothing more. stop acting like you can get rid of the virus by these unscientific decrees.

in the fight against a covert. 90 we've heard of course, from the vaccine from biotech and pfizer mcgurn. a rush says sputnik, obviously also supposedly very effective on so many vaccines in the pipeline. you know, is there a rivalry there? is there a competition there? is this good bad? is there room for all of them? well, this is really important question and to be honest, if this is a business for pharmaceutical being very clear, and this is certainly a market,, for example, if you remember to birds of flies or a c.e.o., it clearly stated that they are not going to subsidize any vaccine just because that's not in favor of the company, but on contrast to ostracize any clearly stated that this is a nonprofit vaccine and therefore the cost is you know, scandal. so there is certainly a rivalry, there's a race. but as it asserted, my concern is more able to safety, i think, ac and the transparency of the data. so we will be bringing all of that information to make clear that whatever vaccine that is ordered into the market is safe and effective and the possible proper checks. so if i under

bill mcgurn, "wall street journal" columnist and editorial board member and marc thiessen, american enterprise institute scholar and fox news contributor. welcome to all of you, good to have all of you tonight. bill, let me begin with you, bill, on this breaking news. it's a very -- it's a real move and it's a symbolic move that the president has now said that the gsa should begin this transition preparation process. >> yeah. i think it's as close as we may get to a concession. and an acknowledgment that the wheels are turning, the space is running out his appeal and you know, my own view is i think the president is entitled to make whatever legal challenge he wants a long as it's constitutional, but i didn't think it would change the results. it doesn't look to have been successful in that direction anywhere, and i think he -- i don't know whether he really will run again in 2024. but i would say he has a much more immediate interest and that is in having those senate races in georgia go republican, because if they don't, a lot of his achievements -- you know, the judges, the revived economy,

and that is something that both companies mcgurn of pfizer have both requested. so pending the outcome of those hearings that will be done through the food and drug administration. what it means is that this is a sort of a process following these phase 3 trials that have occurred and shown in both cases for these vaccines to be extremely effective. that they could quickly be rushed into production and into the marketplace. as early as the end of this year, which is something that president donald trump has repeatedly said would happen and has also been trying to take credit for given the fact that much of these have been developed using funds from what he called operation warp speed. and kambli seems like people didn't take very seriously the government warnings about, you know, the pleas not to travel over thanksgiving. how seriously are they taking the latest talk about people don't really, you know, take it seriously. coming into christmas. well, public health officials are gravely concerned. they issued numerous warnings prior to the american thanksgiving hol

"wall street journal" columnist bill mcgurn joins us now to discuss. good morning to you. hear a bit more from president obama in this piece, listen. >> i'm more troubled by the fact that other republican officials who clearly know better are going along with this. are humoring him in this fashion. it is one more step in delegitimizing -- not just the incoming biden administration, but democracy generally. >> sandra: bill, what do you think of former president obama weighing in on this? >> well, it looks to me as though the obamas didn't get the memo that demonizing your opponents is out. earlier in the week michelle obama in a congratulatory message to mr. biden spoke of trump voters sparked hate and division and former president obama is by not conceding they are threatening democracy. that's just nonsense. again, it makes it look more these calls for national unity are hollow. why not let it play out? i personally don't think it will change the results but as long as the president and his team are doing what's legal asking for recounts, bringing things to the court, let

. >> sandra: let's bring in bill mcgurn main street columnist for the "wall street journal" and former speech writer for george w. bush and fox news contributor. great to see you. everybody starting to form their opinion on what we're seeing as this biden team comes together. laura ingraham gave her thoughts last night. listen. >> biden's entire administration is basically going to look like a rerun of the series canceled four years ago except this time without its popular leading man, obama. now we know what they're going to do. what obama did but it will be worse. >> sandra: do you agree with that, though? >> i generally agree. he wants to distinguish himself from donald trump. they generally fall in the camp of more moderate liberal interventionist. they don't mind intervening overseas as we're doing it through the u.n. or w.h.o. more friendly to deals like the paris accord and iranian deal. if you look at these picks, it is not where the progressive influence is really going to shine. i think the progressives in the democratic party are more concentrating on domestic policy like cl

the man who wrote that piece is bill mcgurn.re i want to share a montage where trump voters might have gotten the idea from. roll tape, please. >> he is knows he is an illegitimate president. he knows. he knows that there were a bunch of different reasons why the election turned out the way it did. >> trump didn't actually win the election in 2016. he lost the election and he was put into office because russians interfered. >> he is illegitimate. my biggest fear he will do it again with the help of vlad his best pal. we'll be stuck for six more years of this guy. that is terrifying. that is terrifying. >> would you be my vice presidential candidate. folks look i absolutely agree. stuart: that says it all, bill, have at it, please. >> yeah. my point was just that the opposition spent the last four years trying to undermine the legitimacy of president trump, even before he stepped into office and in doing this we saw the corruption of so many institutions. we saw the press abandon objectivity. even declare it. we saw the fbi and,

bill mcgurn. always good to see you, sir. thank you. >> sandra: thank you, bill.m pfizer with early data showing their vaccine is more than 90% effective. how do you get it out to the millions of people who need it? how long could this take? we'll get answers from the health and human services secretary alex azar. he is our guest coming up. >> sandra: top stories making headlines this hour. pfizer reporting it's coronavirus vaccine could be 90% effective. >> trace: president-elect joe biden expected to meet with his coronavirus task force any moment. after the meeting he is expected to lay out his plan for tackling the pandemic. >> sandra: president trump promising to fight the election results through the courts appointing recount teams in some swing states to head those efforts. close to 100 people who worked on the trump campaign have deployed to georgia to helpment more on these stories and today's top headlines take a picture of the qr code on the bottom of your screen to get started. >> trace: president trump's legal team is moving ahead on challenging the v

look who's here now, "wall street journal" guy bill mcgurn. of your piece in the "wall street journal" which calls john curry catnip -- john curry catnip for china. exband on that, will ya? expand on that. >> well, not mine personally, "the wall street journal" editorial. look, john kerry's never been a tough negotiator. he put everything in the end into that ridiculous iran deal, and the journal went on to say if he's out there negotiating with china, he's going to come back wearing a barrel instead of clothes, you know? they're just going to take us to the cleaners. so i think this is a bad sign. i think the best we can hope for from the john kerry appointment that is just a lot of preening about climate, so forth, rather than real policy because if he gets into it, i just think it's going to be very expensive for the american people without many real gains to show for it. stuart: i just have to note, bill, that at the moment the dow just hit a new intraday all-time high. you're at 29,955. now, bill, part of that rally is the satisfaction or

story of government for a long time. >> sandra: bill mcgurn from the "wall street journal." appreciate your time. thank you. >> trace: jewish groups are asking the supreme court to step in over new covid restrictions. is new york governor andrew cuomo illegally targeting them? how far will democrats go to win the georgia senate runoffs? a new warning for anyone trying to move to the state just to vote in those races. georgia's secretary of state joins us next. priceline works with top hotels, to save you up to 60%. these are all great. and when you get a big deal... ♪ ...you feel like a big deal. ♪ priceline. every trip is a big deal. my psorii had enough!s pain? ♪ it's not getting in my way. joint pain, swelling, tenderness...much better. my psoriasis, clearer... cosentyx works on all of this. four years and counting. so watch out. i got this! watch me. real people with active psoriatic arthritis look and feel better with cosentyx. cosentyx works fast for results that can last. it treats the multiple symptoms of psoriatic arthritis, like joint pain and tenderness, back pain

bill mcgurn took it up in a piece titled joe biden bitter harvest. where might trump voters got the idea that a president was illegitimate? bill mcburn points to joe biden's own words saturday night in a speech. the grim era of demonization in america has to end. if biden means it he needs to show it. he points to these instances, hillary clinton, jimmy carter, joe biden even back in 2016 who similarly challenged vocally the results of the election when donald trump won. watch. >> he knows he is an illegitimate president. he knows. he knows that there were a bunch of different reasons why the election turned out the way it did. >> trump didn't actually win the election in 2016. he lost the election and put in office because the russians interference. >> he is illegitimate. my biggest fear he will do it again with the help of vp his best pal and we'll be stuck with this guy. >> sandra: that's some of what we've heard over the years. bill, your colleague, where might trump voters got the idea that a president is illegitimate? is that a fair question to

show its vaccine was 94 percent effective with no serious side effects while the filing this stuff mcgurn is product to be the 2nd vaccine likely to receive special authorization after the one developed by by sir and beyond tech. well joining me now is yanis announces he is with the european a public health alliance and is a board member of european medicines agency is known as e m a, which is dealing with murder and as a request for authorization. a very good evening, sir. why do you think we're there now will be granted approval by the way. good evening. it is hard to tell and obviously i don't speak on behalf of the agency, but i will. my message would be that we need to let the regulators do their job. we need to let the regulators look at these, they that we need to make sure that we get these very promising, good news from the companies press releases. we've seen quite a few of them over the past few weeks, but now we need to make sure that there we need to cross-check this data and we need to make sure that the regulators have the time and the tools on their disposal to assess the